Home/Filings/4/0000950170-25-077053
4//SEC Filing

Wong Stephanie 4

Accession 0000950170-25-077053

CIK 0001880438other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 4:56 PM ET

Size

5.1 KB

Accession

0000950170-25-077053

Insider Transaction Report

Form 4
Period: 2025-05-22
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-05-22+19,11119,111 total
    Exercise: $1.19Exp: 2035-05-21Common Stock (19,111 underlying)
Footnotes (1)
  • [F1]The option shares shall vest on March 31, 2026, subject to the Reporting Person providing continuous service through such date.

Documents

1 file

Issuer

AN2 Therapeutics, Inc.

CIK 0001880438

Entity typeother

Related Parties

1
  • filerCIK 0001555744

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:56 PM ET
Size
5.1 KB